correlation between Qavg and LUTS was found by Berry SJ et al. 1 Moreover, a negative correlation between prostate size and LUTS has been found in a study conducted by Singla et al. 15 So, we planned to do this study to see if there actually is a positive correlation between LUTS and Uroflowmetry and LUTS and prostate size, in the people of eastern Nepal. The findings of research may also guide us in measuring the symptoms severity, mode of management and to evaluate efficacy of treatment.
Symptom Scores
The IPSS, initially named the American Urological Association (AUA) Symptom Score, has been developed and established by the committee of the AUA. 19 AUA in 1992 developed the symptom index specifically as an outcome measure in study of different BPH therapies. 15 Presently IPSS has been the most widely used assessment tool in BPH. Validated translations of IPSS have been made in multiple languages making it applicable virtually worldwide. Finally, IPSS results do not appear to be substantially influenced by non clinical factors including race and ethnicity. 20 In IPSS, each question evaluating a combination of urinary storage and voiding symptoms, allows the patient to choose one of the points ranging from 0-5 indicating increasing severity. The total score ranges from 0 to 35 (asymptomatic to very symptomatic).Patients scoring less than 8 points are classified as mildly symptomatic, those scoring 8-19 points are moderately symptomatic and those scoring 20-35 points are severely symptomatic. The IPSS, however, is not specific for BPH. Other urological conditions like urinary tract infections, chronic prostatitis, urethral stricture, neurogenic bladder, and congestive cardiac failure may give rise to LUTS. Thus it should never be used as a tool to screen for or diagnose BPH.
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Uroflowmetry
It is a test to determine the flow rate of urine using an electronic flow meter. The purpose of the uroflow examination is to record one or more micturition that are representative of the patients" usual voiding pattern. The patient is instructed not to urinate for couple of hours and to drink plenty of fluids, until he has an urge to micturate. To perform this test, patient urinates into a special toilet equipped with an uroflowmeter. It is important that the patient remains still while urinating to help ensure accuracy, and that he urinates normally without exerting strain to empty his bladder or attempt to retard his urine flow. The rate of urine flow is calculated as milliliter of urine passed per second (ml/s). At its peak, the flow rate measurement is recorded and referred to as Qmax. Qave is the average amount of urine voided in a unit time and it is expressed as ml/s. Hesitancy time is the time taken to initiate the flow of urine after patient makes an effort to micturate. It is expressed in seconds. Total volume and voiding time are other parameters that can be determined with uroflowmetry. Single episode office uroflowmetry may not be sufficiently reliable for the determination of BOO due to BPH, because many patients are unable to relax and void in the normal fashion while at the clinic. Moreover, since variability between consecutive flow measurements and circadian changes may be found in various voiding parameters, and specifically in Qmax, any decision based on a single flow measurement is questionable (Golomb J et al 1992) .
In a study on "experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia" conducted by Singla et al., it was found that there was a positive correlation between peak flow rate as was measured by uroflowmetry and lower urinary tract symptom severity. 15 A similar study on " significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the IPSS " conducted by Itoh H. et al., demonstrated that age , voiding time and average and maximum flow rates correlates significantly with symptom scores. In particular, relatively strong relationships were found between average flow rate and scores of intermittency, weak stream and total and voiding symptom scores. 16 In a prospective study on "Role of Uroflowmetry in the Assesment of lower urinary tract Obstruction in adult males" by Ismail Shoukry et al., conducted on 173 prostatic patients which was done to determine the respective value of symptoms, uroflowmetry, endoscopic and radiological findings in the assessment of the degree of urinary obstruction, it was confirmed that accurate uroflowmetry is a valuable tool in the assessment of lower urinary tract obstruction in males. Maximum urinary flow rate reflects bladder outlet obstruction better than other parameters 22 In a study on "Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate" by Chalise PR et al., it was concluded that prostate volume had no correlation with age, symptom score, and quality of life score. So prostatic size should not be an only and important consideration; moreover, we should assess the impact of symptoms while treating the cases. 
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II. Aims And Objectives
Correlation Of Uroflowmetry With Lower Urinary Tract Symptoms In Patients With Symptomatic
IV. Methodology
All patients of BPH visiting urology OPD, fulfilling inclusion criteria, were included in the study. These patients were evaluated by using IPSS questionnaire with the assistance of the researchers, and then uroflowmetry was performed on them. The patients were asked to void when they felt a "normal" desire to void, into a special urinal connected to a measuring instrument and adequate privacy was provided to them. The uroflowmetry machine gave the result as peak flow rate, voiding time and voiding volume, among other parameters. The test involved normal urination, hence the patient did not experience any discomfort. The results of uroflowmetry obtained from these patients were also recorded in the preformed proforma.
V. Statistical Analysis
The data was entered, cleaned and coded in Microsoft excel. The data was then exported and analysed through Statistical Package for the Social Sciences (SPSS), version 16.
VI. Results
The mean age of the patients was found to be 65.2 years. A majority of the patients (47.5%) were in the age group of 60-69 years (Fig 1) . As per IPSS scoring, out of 100 patients, 75 had moderate symptoms while 25 had severe symptoms. The mean prostatic size was 39.95, with a range of 22-87. When the patients were divided as per their symptom severity scores, the mean prostatic size in patients with moderate symptoms was 34.65, and that in patients with severe symptoms, it was 55.85. The overall correlation co-efficient of IPSS with prostatic size was found to be 0.533 (Table 1 ). The mean PVRU in patients was 111.84, with a range of 10-504 (Table 2 ). In our study, the mean value of peak flow rate was found to be 31.03 ml/sec, with a minimum recording of 9 ml/sec and a maximum recording of 73 ml/sec (Table 3) The mean average flow rate was found to be 6.242, with a minimum recording of 0.6 and a maximum recording of 17 ml/sec (Table 4 ). In our study, the voided volume was found to have an insignificant relationship with symptom severity (Table-5 ). 
VII. Discussion
This study, which was done on 100 patients, was designed to determine the relationship among the parameters of uroflowmetry and symptom severity. The mean age of the patients in this study was 65.2 years. Most of the patients (47.5%) were in the age group of 60-69 years. Singla et al., in their study displayed almost similar results with patients who had mean age of 67.7 years. Similarly, Mebust et al., in their study reported patients with average age of 69 years. In our study, the mean prostatic size was 39.95 cc, with a range of 22-87.In a similar study conducted on 354 patients by Vesely et al., the average prostate volume was found to be 40.1 cc. Dicuio et al., found average prostate volume to be 41 cc, in a study conducted on 25 men. In another study conducted by Chalise PR, Agrawal CS, the average volume of prostate was 46.1cc. In our study, the mean . However, the p-value in the study was found to be >0.05, which was not significant. In their study, the overall correlation coefficient of IPSS with prostatic size was found to be 0.24. Hence, there was no correlation found between IPSS and prostatic size. Our results were not consistent with previous studies probably due to the fact that patients were uneducated and needed assistance of researchers to fill the questionnaire. In our study, PVRU had a weakly positive correlation (r= 0.451) with severity of urinary symptoms. Consistent with our results, Singla et al., found that PVRU had a weakly positive correlation with severity symptoms.In our study, the mean value of Qmax was found to be 31.03, with a range of 9-73. The Qmax had a weakly positive correlation with symptom score. Similarly, Barry MJ et al., have reported weakly positive correlations between Qmax and symptom score. The mean Qavg in our study was found to be 6.242, with a range of 0.6-17 and on comparing the variables by using Student"s T-test, the p-value was found to be 0.469, not significant. Hence, no significant correlation was found between symptom score and Qavg. A similar result was obtained by Barry MJ, Girman CJ. In our study, the voided volume was found to have an insignificant relationship with symptom severity.
VIII. Conclusion
Of the 100 patients that presented with BPH, most of the patients (47.5%) were in the age group of 60-69 years. It was found that prostate size had moderately positive correlation with LUTS while PVRU was found to have a weakly positive correlation with severity of urinary symptoms. Among the parameters which were obtained by uroflowmetry, Peak flow rate (Qmax) was found to be the most representative of the symptom severity of the patient. Average flow rate (Qavg) and voided volume showed no correlation with the symptoms of the patients. Through our study, we concluded that uroflowmetry is a valuable tool for the diagnosis of patients presenting with Lower Urinary Tract Symptoms. We can also assess the efficacy of our treatment by performing pre operative and post operative uroflowmetry.
